Fund 1 Investments LLC acquired a new position in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 2,500 shares of the company's stock, valued at approximately $975,000.
Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Palisade Asset Management LLC bought a new position in shares of HCA Healthcare in the third quarter valued at approximately $26,000. MidFirst Bank bought a new position in HCA Healthcare during the 2nd quarter valued at $28,000. Clearstead Trust LLC purchased a new stake in shares of HCA Healthcare in the second quarter valued at about $29,000. Cedar Mountain Advisors LLC purchased a new position in HCA Healthcare during the first quarter worth about $33,000. Finally, JPL Wealth Management LLC purchased a new stake in HCA Healthcare in the 3rd quarter valued at about $33,000. 62.73% of the stock is owned by institutional investors.
Analyst Ratings Changes
HCA has been the subject of several recent analyst reports. Weiss Ratings lowered HCA Healthcare from a "buy (b-)" rating to a "hold (c+)" rating in a report on Tuesday, June 9th. The Goldman Sachs Group reduced their price objective on HCA Healthcare from $558.00 to $485.00 and set a "buy" rating for the company in a research note on Tuesday, July 28th. Wells Fargo & Company boosted their price target on shares of HCA Healthcare from $369.00 to $381.00 and gave the stock an "equal weight" rating in a report on Monday, August 3rd. Jefferies Financial Group set a $450.00 price objective on shares of HCA Healthcare in a report on Tuesday, July 14th. Finally, Royal Bank Of Canada reissued an "outperform" rating and set a $435.00 target price on shares of HCA Healthcare in a research report on Monday, July 27th. Fourteen investment analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the company's stock. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and an average price target of $462.64.
View Our Latest Research Report on HCA Healthcare
HCA Healthcare Stock Performance
Shares of HCA Healthcare stock opened at $404.95 on Friday. The stock has a market capitalization of $87.67 billion, a P/E ratio of 13.56, a P/E/G ratio of 1.33 and a beta of 1.10. HCA Healthcare, Inc. has a 52-week low of $353.99 and a 52-week high of $556.52. The stock's 50-day simple moving average is $403.35 and its 200 day simple moving average is $437.55.
HCA Healthcare (NYSE:HCA - Get Free Report) last posted its earnings results on Friday, July 24th. The company reported $7.59 earnings per share for the quarter, topping the consensus estimate of $7.56 by $0.03. HCA Healthcare had a net margin of 8.77% and a negative return on equity of 244.79%. The firm had revenue of $20.23 billion during the quarter, compared to the consensus estimate of $19.76 billion. During the same quarter last year, the company earned $6.84 earnings per share. The company's revenue was up 8.7% on a year-over-year basis. Equities research analysts forecast that HCA Healthcare, Inc. will post 29.42 EPS for the current fiscal year.
HCA Healthcare Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Wednesday, September 30th. Stockholders of record on Wednesday, September 16th will be given a $0.78 dividend. The ex-dividend date is Wednesday, September 16th. This represents a $3.12 annualized dividend and a dividend yield of 0.8%. HCA Healthcare's payout ratio is 10.45%.
About HCA Healthcare
(
Free Report)
HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.
The company's core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA's services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.
Read More
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider HCA Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HCA Healthcare wasn't on the list.
While HCA Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.